Renewal of the GMP certificate for Symeres Prague
This spring, Symeres Prague was audited by the national control authority […]
Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment, amelioration or prevention of cancer
Earlier this year, our client TOLREMO therapeutics nominated the clinical candidate […]
Symeres joins forces with Keensight Capital
Paris (France) – May 25th 2021 We are pleased to let […]
Excellent HTS hits by design, not by accident
The identification of tractable chemical starting points in the drug discovery […]
A follow-up on the European Lead Factory: The Symegold library
Delivery of an innovative 80,000 compound lead-like library for HTS and […]
Feel free to contact us!
Curious to know more about what can we do for you? Get in touch and let’s start a conversation.